The company provided 2026 revenue guidance of $47.5 million to $50 million, representing growth of 15% to 22%. Guidance includes gross margins in the 61% to 63% range, positive adjusted EBITDA, and ...

Developed with LabelMill, Chicago Coding Systems' LM3612 applies high-precision flag labels to small-diameter containers while integrating barcode inspection and data logging for production line ...

Mounjaro - the brand name for tirzepatide - has become one of the most talked-about medications in metabolic health, and for good reason. But the conversation around it has gotten tangled up with ...

Argenx SE (NASDAQ:ARGX) is one of the best NASDAQ stocks to buy according to hedge funds. On February 26, Argenx reported ...

Argenx delivered Q4 2025 product net sales of $1.3B and $4.2B for the full year, up 90% year over year as VYVGART demand accelerated globally. The company reported Q4 operating profit of $367M and ...

BioTechnique broadens capabilities with end‑to‑end fill‑finish, advanced lyophilization development, and integrated ...

Growing numbers of people are injecting unregulated peptides for health reasons - but one expert says they are "lab rats".

Amsterdam, the Netherlands – argenx (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, today reported ...

Eli Lilly on Monday launched a new form of its blockbuster obesity drug, Zepbound, that offers a month's worth of doses in a ...

Full-year 2025 net product revenues of $689 millionSYFOVRE® (pegcetacoplan injection) full year 2025 net product revenue of $587 millionEMPAVELI® ...

The drugmaker is introducing a new, more convenient way to inject its blockbuster obesity drug, Zepbound.

Add Yahoo as a preferred source to see more of our stories on Google. The work at a syringe exchange center, like the one housed at the Damien Center on Indianapolis' east side, doesn't begin and end ...